Section 721.1930 - Butanoic acid, antimony (3=) salt(a)Chemical substance and significant new uses subject to reporting.(1) The chemical substance identified as butanoic acid, antimony (3=) salt (PMN P-94-1143; CAS No. 53856-17-0) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.(2) The significant new uses are: (i)Protection in the workplace. Requirements as specified in § 721.63 (a)(1), (a)(2)(i), (a)(3), (b) (concentration set at 0.1 percent), and (c).(ii)Hazard communication program. Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (g)(1)(i), (g)(1)(vi), (g)(1)(vii), (g)(1)(ix), (g)(2)(i), (g)(2)(v), and (g)(5). The label and SDS as required by this paragraph shall also include the following statement: This substance may cause neurologic effects. This substance may cause cardiovascular effects. This substance may cause ocular irritation.(iii)Industrial, commercial, and consumer activities. Requirements as specified in § 721.80(p) (675,000 kg).(b)Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph.(1)Recordkeeping. Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (e), (f), (g), (h), and (i) are applicable to manufacturers, importers, and processors of this substance.(2)Limitations or revocation of certain notification requirements. The provisions of § 721.185 apply to this section.63 FR 3423, Jan. 22, 1998